Article publication date
14 July 2026
Article review date
29 September 2026
Summary
This prospective cohort study investigated the link between mobile phone use and types of brain tumour, including glioma, glioblastoma, meningioma and acoustic neuroma. It included 467,801 participants aged 40–69 years from the UK Biobank prospective cohort. Participants were originally recruited between 2006-2010 and followed up till 2023. During the 13-year follow-up period, 1,607 brain tumours were identified in the cohort. Participants who had been regular mobile phone users for more than 8 years at recruitment were compared with participants who had never been regular users. No association between mobile phone use and brain tumour was found (Hazard ratio (HR): 0.93, 95% confidence interval (CI): 0.79-1.08). No association with brain tumour was observed among participants reporting the highest weekly call time (>6 hours) (HR: 0.75, 95 % CI: 0.47-1.21) or with any brain tumour type including glioma (HR: 0.78, 95% CI: 0.49-1.24), meningioma (HR: 0.85, 95% CI: 0.46-1.57) or acoustic neuroma (HR: 0.52, 95 % CI: 0.10-2.56). The authors concluded that mobile phone use is not associated with an increased risk of brain tumours.
Published in
SSRN
Link to
Mobile phone use and brain tumour risk: Evidence from the UK Biobank Cohort
ARPANSA commentary
The results are similar to a previous UK Biobank (Zhang et al., 2024) analysis, as well as other large cohort studies like the Danish Cohort Study (Frei et al., 2011) and the Million Women Study (Schüz et al., 2022) and COSMOS Study (Feychting et al., 2024) that all found no association between mobile phone use and brain cancer.
The strength of this UK Biobank study is the prospective nature of the study, and it adds to the literature by conducting a more detailed categorisation of self-reported mobile phone than previous studies (Schüz et al., 2022) to better identify the most exposed users. The self-reported data is an improvement over the Danish Cohort Study (Frei et al., 2011) that only demined exposure based on mobile phone subscriptions which is more prone to exposure misclassification. The COSMOS Study (Feychting et al., 2024) partly addresses this limitation through the use of operator phone usage data in addition to self-reported information. However, neither this or the COSMOS study collected mobile phone use data after baseline recruitment and both studies don’t incorporate the change in mobile phone use over time including and the introduction of the smart phone. Consequently, the weekly call times reported at baseline may not accurately reflect the participants’ mobile phone use during the follow-up period.


